COPPA, Anna
 Distribuzione geografica
Continente #
NA - Nord America 3.037
EU - Europa 1.191
AS - Asia 324
AF - Africa 23
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.597
Nazione #
US - Stati Uniti d'America 3.013
IT - Italia 417
UA - Ucraina 276
IN - India 198
SE - Svezia 187
FI - Finlandia 98
CN - Cina 93
DE - Germania 64
GB - Regno Unito 45
BE - Belgio 24
CA - Canada 24
SG - Singapore 23
TG - Togo 19
BG - Bulgaria 17
IE - Irlanda 17
AR - Argentina 16
FR - Francia 12
NL - Olanda 11
RO - Romania 8
CH - Svizzera 7
IR - Iran 5
BR - Brasile 3
ES - Italia 2
HK - Hong Kong 2
NO - Norvegia 2
PH - Filippine 2
PL - Polonia 2
ZA - Sudafrica 2
CL - Cile 1
EG - Egitto 1
EU - Europa 1
MY - Malesia 1
PE - Perù 1
RS - Serbia 1
RU - Federazione Russa 1
SC - Seychelles 1
Totale 4.597
Città #
Fairfield 393
Chandler 322
Woodbridge 221
Rome 185
Ashburn 169
Houston 163
Seattle 137
Ann Arbor 136
Cambridge 124
Wilmington 123
Jacksonville 113
Princeton 101
Plano 86
Beijing 64
New York 52
Lawrence 50
San Paolo di Civitate 45
Dearborn 43
Boston 38
Millbury 37
Andover 27
Milan 24
San Diego 24
Brussels 20
Helsinki 20
Des Moines 19
Lomé 19
Dublin 17
Grafing 17
Sofia 17
Federal 16
Fremont 16
Norwalk 16
Toronto 15
Boardman 14
Bremen 12
Auburn Hills 10
San Benedetto del Tronto 8
Chennai 7
Phoenix 7
San Mateo 7
Redmond 6
Benevento 5
Laurel 5
London 5
Bern 4
Bethesda 4
Centrale 4
Guangzhou 4
Indiana 4
Montesilvano Marina 4
Nanjing 4
Philadelphia 4
Redwood City 4
Verona 4
Waanrode 4
Buffalo 3
Cardiff 3
Falls Church 3
Kunming 3
Leawood 3
Los Angeles 3
Monte Compatri 3
Montreal 3
Provo 3
Sacramento 3
Sassuolo 3
Southend 3
Troina 3
Washington 3
Americana 2
Anzio 2
Ascoli Piceno 2
Batangas 2
Camerino 2
Civate 2
Columbus 2
Forlì 2
Frosinone 2
Genoa 2
Genzano di Roma 2
Groningen 2
Hefei 2
Henderson 2
Hong Kong 2
Italy 2
Jinan 2
Loreto 2
Montréal 2
Muizenberg 2
Nanchang 2
Onex 2
Oslo 2
Ottawa 2
Parma 2
Potenza 2
Pune 2
Rende 2
Rimini 2
Sorrento 2
Totale 3.101
Nome #
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 137
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer. 120
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma 113
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 109
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 99
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors 92
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 87
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14. 87
Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer 86
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families 84
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 84
A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours 81
Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer 81
Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data 79
Coexistence of three EGFR mutations in an NSCLC patient: A brief report 76
The role of peroxiredoxins in cancer 75
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 74
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report 74
A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression 73
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology 68
Overexpression of TGFb type II receptor in human neuroblastoma cells reduces cell growth and induces neuronal phenotype 68
Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy 68
Nuclear fluorescence serum reactivity on monkey oesophagus: a new antibody for the follow-up of coeliac disease? 65
Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes 65
HE4 in the differential diagnosis of a pelvic mass: A case report 64
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk 61
EGF and TGF-β1 effects on thyroid function 60
The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration 59
Analysis of TGFb receptors expression in normal and TGFb resistant rat thyroid cells 58
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 58
Epithelial rat thyroid cell clones, excaping from TGFbeta negative control, are still inhibited by this factor in the ability to trap iodide 56
SMAD NUCLEOCYTOPLASMIC SHUTTLING IN THE THYROID TUMORIGENESIS. 55
Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin. 54
Role of reduced expression of SMAD4 in papillary thyroid carcinoma 51
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms 50
The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals 49
A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases 49
Role of Smads in the tumorigenicity and metastatic potential of K-ras transformed thyroid cells. 48
Smad4 control of rat thyroid follicular cells differentiation 48
A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma 47
Effects of the Smad4 C324Y mutation on thyroid cell proliferation 46
TGFb1 enhances the invasiveness of human MDA-MB-231 breast cancer cells up-regulating urokinase activity 46
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study 44
Effetti sulla proliferazione e sulle funzioni di cellule di tiroide normali e TGFb resistenti 44
TGFbeta regulates differentiation and proliferation of human neuroblastoma 43
Okadaic acid influences thyroid cell proliferation 42
Loss of TGFb mediated growth regulation in transformed thyroid cells is associated with alterations in the expression of TGFb receptors. 42
CTNNB1 p.L31P mutation in an ovarian endometrioid carcinoma with synchronous uterine endometrioid carcinoma 42
Increased expression of cyclin D1 is associated with reduced levels of type II TGFb receptor (TbRII) in malignant thyroid cells 41
Serum gastrin, fasting and afterstimulation, in systemic sclerosis 41
Increased expression of cyclin D1 is associated with impairment of TGFb-growth inhibitory signal at the level of either type II receptor (TbRII) or Smad proteins in Ras-transformed rat thyroid cells and in human thyroid tumours.. 40
A novel BRCA2 splice variant identified in a young woman 40
Reduction of TGFb receptor type II correlates with resistence in TGFb growth inibition in rat thyroid cells. 39
Oncogenes and antioncogenes involved in human thyroid carcinogenesis 39
Analysis of expression of TGFb growth factor receptors in benign and malignant thyroid tumors 38
Increased type II TGFbeta receptor expression in liver cells during cholesterol challenge 37
Evaluation using radioisotopes (I125) of the artightness of root canal obturation obtained with lateral and vertical condensation technics 37
TGFb activates divergent postreceptorial pathways in epithelial rat thyroid cells in culture 37
Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastatic potential of K-ras-transformed thyroid cells. 37
Breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers using polygenic risk scores 37
Loss of TGFb mediated growth regulation in K-Ras transformed thyroid cells is asssociated with reduced expression of Type II TGFb Receptor. 36
Monitoring of serum alpha-fetoprotein levels in children with chronic hepatitis B virus infection 36
Increased TGFb type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells. 36
SMAD-4 altered nucleo-cytoplasmic shuttling in thyroid tumours: a new intriguing link in cancer development 35
Il recettore di tipo II del TGFb si comporta come un antioncogene quando é overespresso in cellule di tiroide trasformate 34
Molecular mechanism of thyroid neoplastic transformation 34
Expression of diamine oxidase (DAO), sucrose and CEA in human colon CaCO-2 cell line 34
Smad4 altered expression is a new important step of TGF-BETA signal impairment in thyroid tumorigenesis 32
Increased TbRII expression reduces tumorigenicity and induces neuronal differentiation of human neuroblastoma cells 31
Markers neoplastici e sierici nelle poliposi del colon-retto 31
TGF-b1 signalling in K-ras transformed thyroid cells 31
Regulation of MHC Class I gene expression: role of TGFb1 31
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance 30
Alterations of TGFb pathway in neoplastic thyroid cells 29
Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway 29
Special volunteer 29
TGFbeta downregulation of MCH class I in thyreocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors 29
Restored expression of TGFb type II receptor in k-ras transformed thyroid cells, TGFb resistant, reverts their malignant phenotype 29
NSD1 mutations and pediatric high-grade gliomas: a comparative genomic study in primary and recurrent tumors 28
Transforming growth factor beta-1 treatment of human MDA-MB-231 breast cancer cells stimulates plasmin dependent MMP-9 and membrane dependent MMP-2 activation 28
THE PHOSPHATASE INHIBITOR OKADAIC ACID STIMULATED THE TSH-INDUCED G1-S PHASE TRANSITION IN THYROID CELLS 28
Erb-B2 overexpression alters the rat cells response to growth factors. 26
Carcinoma del colon: correlazione tra l'espressione del recettore per l'EGF e markers tumorali tissutali 26
TGFb effects on expression of cyclins and cyclin-dependent kinases in rat thyroid cells 24
Livelli sierici di Tissue Polypeptide Antigen (TPA) in soggetti affetti da malattie ematiche 24
TGFb type II recepor acts as antioncogene when overexpressed in human neuroblastoma cells. 24
Visiting fellow 24
Overexpression of TGFb receptor type II (TbRII) reduces malignant phenotype of K-Ras-transformed thyroid cells 24
Association of screening for congenital adrenal hyperplasia with that of congenital hypotiroidism: microfilter paper method for 17- hydroxyprogesterone radioimmunoassay 24
Correlazione tra l'espressione del recettore per l'EGF ed alcuni markers tumorali tissutali in tiroidi umane con patologia benigna e maligna 24
Epidermal growth factor receptor and tissue tumor markers in human intracranial neoplasms 23
TGF-beta control of rat thyroid follicular cells differentiation 21
L'endemia gozzigena in Campania: indagine nella provincia di Caserta 21
Role of Smad4 in the regulation of thyroid differentiation genes. 16
Thyroid function and etiological factors in same areas of endemic goitier in south of Italy 15
Recenti acquisizioni sugli indicatori biochimici presenti nel siero, nel liquido di lavaggio bronchiale e nel tessuto polmonare di soggetti affetti da patologia neoplastica 13
Thyroid tumors display reduced levels of TGFb receptor type II m-RNA and protein 13
Expression of diamine oxidase, sucrose and CEA in differentiating colon cancer cells. 12
Visiting Researcher presso il Laboratorio di DNA Repair 12
ENIGMA CHEK2gether Project. A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk 11
Totale 4.761
Categoria #
all - tutte 12.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019290 0 0 0 0 0 0 0 0 39 55 127 69
2019/20201.036 138 52 20 56 67 134 127 131 83 122 66 40
2020/2021481 52 68 11 27 10 69 6 37 35 128 35 3
2021/2022947 14 66 72 52 121 22 22 88 64 79 171 176
2022/20231.094 208 212 82 106 118 114 37 54 89 16 38 20
2023/2024440 46 61 41 34 72 97 47 40 2 0 0 0
Totale 4.771